The cervical cancer vaccine is available for ages 9-45.
Cervical cancer vaccine refers to human papillomavirus (HPV) vaccine, which is clinically categorized into bivalent, quadrivalent and septavalent, and all of them are available at the age of 9-45 years. Early vaccination is recommended for those who meet the vaccination age.
People who have hypersensitivity to the active ingredient of the vaccine or any of the excipient components are prohibited from receiving HPV vaccine, and those who have symptoms of hypersensitivity after injection of this product should not receive this product again.
HPV vaccine is a prophylactic vaccine and cannot treat infected HPV and related diseases, prevent all HPV types of infections, or stop HPV infections from progressing to disease progression. Therefore regular visits to the hospital for cervical cancer screening are still needed.